Levodopa vs Pembrolizumab

## Levodopa vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Levodopa** and **Pembrolizumab**.

## Mechanism of Action

**Levodopa**: Metabolic precursor of dopamine that crosses the BBB.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Levodopa — 1.5 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Levodopa — C9H11NO4; Pembrolizumab — N/A.

**Molecular Weight**: Levodopa — 197.1880 g/mol; Pembrolizumab — N/A.

**Type**: Levodopa — Small molecule; Pembrolizumab — Antibody.